PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $445,616 | +6265.9% | 201,636 | +7250.9% | 0.00% | – |
| Q1 2023 | $7,000 | +233233.3% | 2,743 | +67.7% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 1,636 | -58.7% | 0.00% | – |
| Q3 2022 | $10,000 | +150.0% | 3,958 | +91.9% | 0.00% | – |
| Q2 2022 | $4,000 | -95.3% | 2,063 | -92.9% | 0.00% | – |
| Q1 2022 | $86,000 | -14.9% | 28,946 | +28.9% | 0.00% | – |
| Q4 2021 | $101,000 | -1.9% | 22,449 | +5.2% | 0.00% | – |
| Q3 2021 | $103,000 | -24.3% | 21,337 | +7.5% | 0.00% | – |
| Q2 2021 | $136,000 | +18.3% | 19,857 | +21.1% | 0.00% | – |
| Q1 2021 | $115,000 | -5.0% | 16,403 | -15.1% | 0.00% | – |
| Q4 2020 | $121,000 | +36.0% | 19,310 | +18.8% | 0.00% | – |
| Q3 2020 | $89,000 | +23.6% | 16,258 | +18.5% | 0.00% | – |
| Q2 2020 | $72,000 | +118.2% | 13,715 | +30.6% | 0.00% | – |
| Q1 2020 | $33,000 | -99.5% | 10,501 | -99.3% | 0.00% | -100.0% |
| Q4 2019 | $6,171,000 | +389.0% | 1,531,181 | +424.3% | 0.00% | – |
| Q3 2019 | $1,262,000 | +17.0% | 292,048 | +4.2% | 0.00% | – |
| Q2 2019 | $1,079,000 | -32.6% | 280,228 | -6.2% | 0.00% | – |
| Q1 2019 | $1,602,000 | -1.8% | 298,814 | -6.0% | 0.00% | – |
| Q4 2018 | $1,631,000 | -50.1% | 317,946 | -5.7% | 0.00% | -100.0% |
| Q3 2018 | $3,271,000 | +1.3% | 337,110 | +6.5% | 0.00% | 0.0% |
| Q2 2018 | $3,229,000 | +9.3% | 316,634 | +39.4% | 0.00% | 0.0% |
| Q1 2018 | $2,953,000 | -33.6% | 227,164 | -8.5% | 0.00% | 0.0% |
| Q4 2017 | $4,446,000 | +9.8% | 248,377 | +54.5% | 0.00% | 0.0% |
| Q3 2017 | $4,051,000 | -15.8% | 160,781 | -19.5% | 0.00% | 0.0% |
| Q2 2017 | $4,813,000 | +2406.8% | 199,725 | +1898.2% | 0.00% | – |
| Q1 2017 | $192,000 | -44.0% | 9,995 | -55.2% | 0.00% | – |
| Q4 2016 | $343,000 | -89.6% | 22,301 | -89.7% | 0.00% | -100.0% |
| Q1 2016 | $3,290,000 | -20.0% | 216,902 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $4,115,000 | -0.2% | 216,902 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $4,123,000 | -26.2% | 217,017 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $5,590,000 | -17.6% | 216,902 | -0.1% | 0.00% | -50.0% |
| Q1 2015 | $6,787,000 | – | 217,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |